BMI1 and head and neck squamous cell carcinoma: Although Bmi-1 has not been identified as a marker for HNSCC CSCs in its own right, its tumourigenic capacities and increased levels in ALDH1+ subpopulations have made it a target of examination and is considered a critical factor in predicting disease progression and clinical outcomes [42].